Literature DB >> 15645376

Susceptibility of different eukaryotic cell lines to SARS-coronavirus.

K Hattermann1, M A Müller, A Nitsche, S Wendt, O Donoso Mantke, M Niedrig.   

Abstract

In order to define and characterize target cells of SARS-coronavirus (SARS-CoV) we studied the susceptibility of 23 different permanent and primary eukaryotic cell lines to SARS-coronavirus. Beneath Vero E6 cells SARS- Coronavirus infection could also be demonstrated in two pig cell lines (POEK, PS) and one human cell line (Huh-7) using the indirect immunofluorescence assay and a newly established quantitative real-time PCR. In all susceptible cell lines mRNA of the Angiotensin-converting enzyme 2 (ACE2), the functional receptor for SARS-CoV infection, could be detected by RT-PCR. Our results show that there is a correlation between the abundance of ACE2 mRNA and SARS-CoV susceptibility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645376      PMCID: PMC7086824          DOI: 10.1007/s00705-004-0461-1

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells.

Authors:  Aleksandra Milewska; Miroslaw Zarebski; Paulina Nowak; Karol Stozek; Jan Potempa; Krzysztof Pyrc
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

Review 2.  Attachment factor and receptor engagement of SARS coronavirus and human coronavirus NL63.

Authors:  Heike Hofmann; Andrea Marzi; Thomas Gramberg; Martina Geier; Krzysztof Pyrc; Lia van der Hoek; Ben Berkhout; Stefan Pöhlmann
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

3.  A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo.

Authors:  Marta L DeDiego; Enrique Alvarez; Fernando Almazán; María Teresa Rejas; Elaine Lamirande; Anjeanette Roberts; Wun-Ju Shieh; Sherif R Zaki; Kanta Subbarao; Luis Enjuanes
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

4.  Human coronavirus NL63 open reading frame 3 encodes a virion-incorporated N-glycosylated membrane protein.

Authors:  Marcel A Müller; Lia van der Hoek; Daniel Voss; Oliver Bader; Dörte Lehmann; Axel R Schulz; Stephan Kallies; Tasnim Suliman; Burtram C Fielding; Christian Drosten; Matthias Niedrig
Journal:  Virol J       Date:  2010-01-15       Impact factor: 4.099

Review 5.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

6.  Antiviral activities of ISG20 in positive-strand RNA virus infections.

Authors:  Zhi Zhou; Nan Wang; Sara E Woodson; Qingming Dong; Jie Wang; Yuqiong Liang; Rene Rijnbrand; Lai Wei; Joan E Nichols; Ju-Tao Guo; Michael R Holbrook; Stanley M Lemon; Kui Li
Journal:  Virology       Date:  2010-10-30       Impact factor: 3.616

7.  Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis.

Authors:  Marta L DeDiego; Jose L Nieto-Torres; Jose M Jiménez-Guardeño; Jose A Regla-Nava; Enrique Alvarez; Juan Carlos Oliveros; Jincun Zhao; Craig Fett; Stanley Perlman; Luis Enjuanes
Journal:  PLoS Pathog       Date:  2011-10-20       Impact factor: 6.823

8.  Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice.

Authors:  Marta L Dediego; Lecia Pewe; Enrique Alvarez; Maria Teresa Rejas; Stanley Perlman; Luis Enjuanes
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

Review 9.  In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses.

Authors:  Saeid Najafi Fard; Linda Petrone; Elisa Petruccioli; Tonino Alonzi; Giulia Matusali; Francesca Colavita; Concetta Castilletti; Maria Rosaria Capobianchi; Delia Goletti
Journal:  Biomed Res Int       Date:  2021-06-21       Impact factor: 3.411

10.  Plaque assay for human coronavirus NL63 using human colon carcinoma cells.

Authors:  Petra Herzog; Christian Drosten; Marcel A Müller
Journal:  Virol J       Date:  2008-11-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.